Equitech International Competitors
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
TMO | Thermo Fisher Scientific | Outperform |
10
|
$573.55 | $591.94 | 8.10% | 1 | $218.93B |
DHR | Danaher | Outperform |
10
|
$247.40 | $260.33 | 10.12% | 4 | $183.25B |
A | Agilent Technologies | Outperform |
10
|
$140.61 | $138.82 | 7.39% | 10 | $41.21B |
MTD | Mettler-Toledo International | Hold |
13
|
$1.25k | $1.12k | -2.38% | 0 | $26.75B |
WAT | Waters | Hold |
15
|
$319.86 | $323.50 | 3.17% | 2 | $18.97B |
ILMN | Illumina | Outperform |
16
|
$118.98 | $159.28 | 21.87% | 9 | $18.95B |
AVTR | Avantor | Outperform |
16
|
$24.87 | $23.25 | 12.59% | 19 | $16.89B |
PKI | PerkinElmer | Outperform |
16
|
$102.82 | $121.84 | 20.48% | 1 | $12.49B |
BRKR | Bruker | Outperform |
16
|
$72.52 | $73.64 | 18.59% | 1 | $10.18B |
BIO | Bio-Rad Laboratories Inc | Outperform |
16
|
$281.97 | $536.80 | 50.73% | 1 | $7.74B |
COHR | Coherent | - |
12
|
$33.97 | $258.00 | -100.00% | 0 | $6.61B |
LAB | Standard BioTools | Buy |
11
|
$2.48 | $4.00 | 41.13% | 1 | $948.50M |
PACB | Pacific Biosciences of Califor... | Outperform |
9
|
$1.99 | $12.67 | 75.88% | 4 | $449.37M |
HBIO | Harvard Bioscience | Buy |
14
|
$3.92 | $7.00 | 78.57% | 2 | $165.87M |
ENZ | Enzo Biochem | - |
8
|
$1.36 | $5.50 | -100.00% | 0 | $62.10M |
DYXC | DiaSys | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.03M |
ASPT | Haber | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.02M |
MDIT | Medite Cancer Diagnostics | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.01M |
OMRX | Orthometrix | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |
LFPI | LifePoint | - |
0
|
$0.00 | $5.50 | 0.00% | 0 | $0.00M |